BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1700059)

  • 1. The significance of abnormally high and low maternal serum alpha-fetoprotein levels between 14 and 25 weeks of gestation.
    Ko TM; Hsieh FJ; Wu CC; Chang CH; Hsieh RF; Liu IJ; Hsieh CY; Lee TY
    J Formos Med Assoc; 1990 Jun; 89(6):456-60. PubMed ID: 1700059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum alpha fetoprotein among pregnant females in Alexandria.
    Baghagho EE; Kharboush IF; El-Kaffash DM; KarKour TA; Ismail SR; Mortada MM
    J Egypt Public Health Assoc; 2004; 79(1-2):59-81. PubMed ID: 16916050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation].
    Hayashi M; Kohzu H
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
    J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trisomy 18 and maternal serum and amniotic fluid alpha-fetoprotein.
    Lindenbaum RH; Ryynänen M; Holmes-Siedle M; Puhakainen E; Jonasson J; Keenan J
    Prenat Diagn; 1987 Sep; 7(7):511-9. PubMed ID: 2444965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester alpha-fetoprotein screening for Down syndrome.
    Fuhrmann W; Altland K; Jovanovic V; Holzgreve W; Miny P; Wenger D; Rauskolb R
    Prenat Diagn; 1993 Mar; 13(3):215-8. PubMed ID: 7685089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
    Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
    Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between weights of fetuses with autosomal trisomies and low maternal serum alpha-fetoprotein].
    Hsu JJ; Hsieh CC; Chiu TH; Soong YK
    Changgeng Yi Xue Za Zhi; 1992 Mar; 15(1):33-8. PubMed ID: 1374679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome].
    Bessho T; Kanazawa R; Shiotani T; Mitsuo M; Koyama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):237-43. PubMed ID: 7535328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very low second-trimester maternal serum alpha-fetoprotein: Association with high birth weight.
    Baschat AA; Harman CR; Farid G; Chodirker BN; Evans JA
    Obstet Gynecol; 2002 Apr; 99(4):531-6. PubMed ID: 12039105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum alpha-fetoprotein levels between 13 and 24 weeks' gestation.
    Hsu JJ; Chiu TH; Chen KC; Liou JD; Hseih TT; Soong YK
    Changgeng Yi Xue Za Zhi; 1994 Dec; 17(4):309-15. PubMed ID: 7531609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
    Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
    J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of MSAFP screening on genetic services, 1984-1986.
    Greenberg F
    Am J Med Genet; 1988 Sep; 31(1):223-30. PubMed ID: 2464932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly.
    Yaron Y; Hamby DD; O'Brien JE; Critchfield G; Leon J; Ayoub M; Johnson MP; Evans MI
    Am J Med Genet; 1998 Jan; 75(3):297-9. PubMed ID: 9475601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early pregnancy screening for neural tube defects in Israel.
    Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
    Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonography in patients with low maternal serum alpha-fetoprotein.
    Nelson LH; Burton BK; Sowers S
    J Ultrasound Med; 1987 Feb; 6(2):59-61. PubMed ID: 2435923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.